AIDS and Chimpanzees

My understanding of the science and politics surrounding the use of chimpanzees in AIDS research was greatly enhanced by your recent article.1 However, the column erroneously reported that there is no small-animal AIDS model. Feline immunodeficiency virus (FIV) infection of domestic cats causes disease that is clinically indistinguishable from HIV-1 infection in humans. Cats are relatively inexpensive to maintain, have a short breeding cycle, and pose less of a zoonotic-disease threat to their

Written byArlin Rogers
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

My understanding of the science and politics surrounding the use of chimpanzees in AIDS research was greatly enhanced by your recent article.1 However, the column erroneously reported that there is no small-animal AIDS model. Feline immunodeficiency virus (FIV) infection of domestic cats causes disease that is clinically indistinguishable from HIV-1 infection in humans. Cats are relatively inexpensive to maintain, have a short breeding cycle, and pose less of a zoonotic-disease threat to their handlers than do nonhuman primates. Antiviral therapies for HIV have shown generally similar efficacy and toxicity when administered to FIV-infected cats. Culture-adapted strains of FIV utilize the CXCR-4 receptor, just as do T-tropic strains of HIV. The similarities between HIV-1 and FIV are too numerous to list here.

There is a small but vibrant worldwide community of FIV research laboratories publishing new information on lentiviral pathogenesis, intervention, and vaccination strategies. Regrettably, many HIV researchers are unaware of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies